Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial

Michael Haude, Hüseyin Ince, Alexandre Abizaid, Ralph Toelg, Pedro Alves Lemos, Clemens von Birgelen, Evald Høj Christiansen, William Wijns, Franz-Josef Neumann, Christoph Kaiser, Eric Eeckhout, Soo Teik Lim, Javier Escaned, Hector M. Garcia-Garcia, Ron Waksman

Research output: Contribution to journalArticleAcademicpeer-review

239 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial'. Together they form a unique fingerprint.

Medicine & Life Sciences